Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07449195

A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors

Ocular Imaging for Monitoring of Ocular Tumor Disease

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Memorial Sloan Kettering Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare two devices used for optical coherence tomography (OCT). OCT is a noninvasive imaging (scanning) method that uses reflected light to create pictures of the back of the eye, and doctors can use OCT to detect and monitor different types of cancer

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTIntalight Dream OCTThis is a next-generation swept-source device that has a faster imaging speed and higher sensitivity than the previous generation of frequency-domain OCT devices, which serve as the current standard of care devices.
DIAGNOSTIC_TESTHeidelberg Spectralis OCTThis is the standard of care for optical imaging.

Timeline

Start date
2026-02-27
Primary completion
2028-02-27
Completion
2028-02-27
First posted
2026-03-04
Last updated
2026-03-04

Locations

7 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT07449195. Inclusion in this directory is not an endorsement.

A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors (NCT07449195) · Clinical Trials Directory